Home LiteratureArticle Details
PMID: 2285289 Published · ppublish English Journal Article

Mathematical modeling of antimicrobial susceptibility data of Staphylococcus haemolyticus for 11 antimicrobial agents, including three experimental glycopeptides and an experimental lipoglycopeptide.

Antimicrobial agents and chemotherapy ·Vol. 34 ·No. 9 ·1990-09-00 ·Pages 1769-72

Hunter PR, George RC, Griffiths JW

Abstract

Antimicrobial MIC data were obtained for 96 strains of Staphylococcus haemolyticus and the following 11 antimicrobial agents: methicillin, gentamicin, rifampin, fusidic acid, ciprofloxacin, vancomycin, teicoplanin; three experimental glycopeptides, MDL 62,873, MDL 62,208, and MDL 62,224; and an experimental lipoglycopeptide, ramoplanin. Resistance to methicillin and gentamicin was present in over 50% of the strains, although resistance to the other agents was present in less than 10%. It is shown how application of mathematical modeling techniques can add to the understanding of such MIC data. MICs of methicillin and gentamicin were highly correlated, suggesting that evolutionary pressures for development of resistance to these agents were similar. The structural relationships among the glycopeptides were accurately reflected in their spatial relationships within the model. MICs of ramoplanin were negatively correlated with MICs of some other antimicrobial agents, particularly gentamicin, suggesting that this agent is more active against gentamicin-resistant strains. Methicillin-resistant strains were more tightly clustered than were methicillin-susceptible strains, suggesting that methicillin-resistant strains were more closely related to each other than were methicillin-susceptible strains. Mathematical modeling techniques enable more detailed analysis of MIC data.

MeSH Terms
Anti-Bacterial Agents/pharmacology Drug Interactions Glycopeptides/pharmacology Microbial Sensitivity Tests Models, Biological Models, Statistical Staphylococcus/drug effects
Chemicals
Anti-Bacterial Agents Glycopeptides
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Hunter P R
Public Health Laboratory, City Hospital, Chester CH2, England.
George R C
Griffiths J W
References (8)
8 references, click to expand
  1. Synthesis and biological properties of N63-carboxamides of teicoplanin antibiotics. Structure-activity relationships.
    J Med Chem. 1989 Nov;32(11):2450-60 PMID: 2530352
  2. Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus.
    Antimicrob Agents Chemother. 1989 Apr;33(4):460-6 PMID: 2729941
  3. Emergence of vancomycin resistance in coagulase-negative staphylococci.
    N Engl J Med. 1987 Apr 9;316(15):927-31 PMID: 3821839
  4. Antimicrobial resistance in coagulase-negative staphylococci.
    J Med Microbiol. 1985 Apr;19(2):217-26 PMID: 3845121
  5. Species identification and antibiotic sensitivity of coagulase-negative staphylococci from CAPD peritonitis.
    J Antimicrob Chemother. 1984 Jun;13(6):577-83 PMID: 6332107
  6. Species identification of coagulase-negative staphylococcal isolates from blood cultures.
    J Clin Microbiol. 1982 Mar;15(3):439-42 PMID: 6918401
  7. Species identification and susceptibility to 17 antibiotics of coagulase-negative staphylococci isolated from clinical specimens.
    J Clin Microbiol. 1982 Apr;15(4):640-5 PMID: 7068839
  8. Ivestigation of coagulase-negative staphylococci from infections in surgical patients.
    Zentralbl Bakteriol Orig A. 1978 Jul;241(1):140-56 PMID: 696065
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1990-09-00
Pages
1769-72
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC171921
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]